Skip to main content
. 2026 Sep 9;46:100457. doi: 10.1016/j.jcte.2026.100457

Table 2.

Associations with depression in patients with newly diagnosed T2DM.


Depression
COR (CI 95%) P AOR (CI 95%) Pa
Age (per year) 0.99 (0.97–1.00) <0.11 – –
Sex (women) 1.8 (1.2–2.7) 0.003 1.3 (0.8–2.2) 0.26
Anxiety 10.2 (6.6–15.7) <0.001 10.5 (6.3–17.4) <0.001
Antidepressants 3.3 (1.9–5.7) <0.001 – –
sTREM2 quintiles (pg/mL) >3.38 2.0 (1.1–3.7) 0.023 – –
>2.28 – ≤3.38 1.4 (0.7–2.6) 0.31 – –
>1,71 – ≤2.28 0.9 (0.5–1.8) 0.83 – –
>1.27 – ≤1,71 0.9 (0.46–1.8) 0.76 – –
≤1,27 1 – –
High sTREM2 (≥1.60 nmol/L) 1.9 (1.2–3.0) 0.004 2.0 (1.1–3.5) <0.016
Low sNeuropilin-1 (<225.5 ng/mL) 3.2 (2.1–4.9) <0.001 3.3 (2.0–5.5) <0.001
High C-peptide (≥1.60 nmol/L) 1.7 (1.1–2.7) 0.009 1.9 (1.1–3.2) 0.024
HbA1c (per %) 1.0 (0.9–1.1) 0.43 – –
(per mmol/mol) 1.00 (0.99–1.01) – –
BMI (per kg/m2) 1.05 (1.01–1.08) <0.006 1.02 (0.97–1.06) 0.44
Physical inactivity 1.8 (1.1–2.7) 0.010 1.8 (1.1–3.0) 0.025
Smoking 1.7 (1.0–2.9) 0.043 1.3 (0.7–2.5) 0.41
Stroke/TIA (prior) 0.8 (0.4–1.8) 0.61 – –
Myocardial infarction (prior) 1.1 (0.6–2.1) 0.69 – –
a

Logistic regression (Backward: Wald): n = 630; Omnibus Tests of Model Coefficients p < 0.001; Nagelkerke R2 0.336.